re: yes - agree completely - stockslut
yes stockslut, the management need to capitalize on this aproval - all that aproval means, is that the US market is more readily available to the company. the next step is this "reimbursement" thing that they mention. my understanding is that the company wants to be reimbursed at a different (higher) level, from other competing products. the company has its own category in the english nhs, for its flagship product - VACUTEX. as i mentioned in my previous post, the company needs to get hospital contracts - and these can only be obtained as existing contracts expire.
good management, good product, and business moving according to plan. well worth finding out about the product - an internet search would be most rewarding. i did this along time ago, and have heaps of this stock
AVP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
